Biggest News Aggregation in the World
📰 Segments Profiled News

Page 27 - Segments Profiled News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Segments Profiled. Real-time updates on events, politics, business and more.

Mammography Market | Hologic, Inc., PLANMED OY, Konica Minolta, GENERAL ELECTRIC Inc. | By 2032

The global Mammography Market demand is estimated to be worth around US$ 1.7 Billion in 2022. However, with rising prevalence of breast cancer at an alarming rate the overall demand for mammography systems is anticipated to grow at around 6.5% to 9% CAGR between 2022 and 2032, totaling over US$ 3.4 Billion by 2032.M...
New York United States Koninklijke Philips American College Of Radiology Diagnosis Centers General Electric Inc

Eltrombopag and Romiplostim Therapies Emerging as Effective Second-Line Chronic Immune Thrombocytope

Future Market Insights in its latest report predicts Korea Thrombocytopenia Treatment Market to progress at around 3.5% to 4.0% CAGR between 2023 and 2033. Sales of thrombocytopenia medication in the global market are slated to rise at a CAGR of 5.2% throughout the forecast period (2023 to 2033).Introduction of new...
New York United States Market Insights Inc Sample Of Research Karyopharm Therapeutics Inc Greater New York Chamber

Increased funding and expenditure in pharmaceuticals and biotechnology R&D procedures are propelling

The South Korean Laboratory Supplies Market is predicted to reach US$ 1 billion by 2032. The market is primarily driven by increased funding and investment in pharmaceutical and biotechnology R&D operations. Because of the consistent and predictable supply of laboratory equipment, the market is projected to expand a...
New York United States South Korea South Korean Agilent Technologies Inc Laboratory Supplies Market Industry

Hyperpigmentation Treatment Market is expected to reach a valuation of US$ 11.84 Billion by 2033 | F

The global Hyperpigmentation Treatment Market is estimated to amass a revenue of US$ 11.84 billion by 2033, with sales growing at a robust CAGR of 8.6% from 2023 to 2033. Predicted to reach US$ 4.78 billion in 2023, the target market is shaped by increasing demand for outpatient and microsurgical procedures, constan...
New York United States Vivier Pharma Asia Pacific Pierre Fabre Dermo Cosmetique Market Insights Inc

Eisenmenger Complex Management Market to reach US$ 12.9 billion in 2033, Endothelin Receptors to acc

The global Eisenmenger complex management market is expected to surpass an impressive valuation of US$ 7.7 billion in 2023 and is projected to reach US$ 12.9 billion by 2033, growing at a CAGR of 5.3%. Generally, the treatment includes relieving the symptoms and associated co-morbidities. Medications such as calcium...
New York United States United Arab Emirates Acceleron Pharma Gossamer Bio Inc Eisenmenger Complex Management Industry

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Promising Results from Gene Delivery and Enzyme Replacement Therapies to Revolutionize the USA Fucos

According to Future Market Insights, North America is anticipated to hold around 25% share in the global fucosidosis therapeutics market during the forecast period. Within North America, the USA fucosidosis therapeutics market is predicted to exert a domineering influence throughout the projected period.Advanced the...
New York United States United Arab Emirates National Institutes Of Health Greater New York Chamber Fucosidosis Therapeutics Industry

Erythema Treatment Market value of US$ 315 Million by registering a CAGR of 5.5% in the forecast per

During the forecast period 2023 to 2033, the Erythema treatment market is expected to grow at a value of 5.5% CAGR, according to Future Market Insights. By the year 2033, the global market for Erythema treatment is expected to rise up to a market valuation of US$ 184.41 Million. Growth of the market can be attribute...
New York United States United Arab Emirates Bausch Health Companies Inc Valeant Pharmaceuticals International Inc Regeneron Pharmaceuticals Inc

Epidemic Keratoconjunctivitis Treatment Market value of US$ 500 million in 2023

The global epidemic keratoconjunctivitis treatment market is expected to garner a market value of US$ 500 million in 2023 and is expected to accumulate a market value of US$ 814.45 million by registering a CAGR of 5% in the forecast period 2023 to 2033. The market for Epidemic Keratoconjunctivitis Treatment register...
New York United States United Arab Emirates Asia Pacific Ocuphire Pharma Epidemic Keratoconjunctivitis Treatment Industry

Common Warts Market is expected to garner a value of US$ 1100 Million by 2033

A recently published study by FMI expects the global common warts market to augment at a 3.6% CAGR from 2023 to 2033. By the end of the said assessment period, a valuation of US$ 1,100 Million is expected for the market. The increase in pharmaceutical R&D activity for efficient and focused treatment of common warts...
New York United States Asia Pacific Nielsen Biosciences Aclaris Therapeutics Inc Torii Pharmaceutical Co Ltd

Hematopoietic Stem Cell Transplantation Market to grow at an 8% CAGR until 2033, reaching US$ 15 Bil

A recently published study by FMI expects the global Hematopoietic Stem Cell Transplantation Market to augment at an 8% CAGR from 2023 to 2033. By the end of the said assessment period, a valuation of US$ 15 Billion is expected for the market. The hematopoietic stem cell transplantation market has grown fast in rece...
New York United States Asia Pacific Cellgenix Gmb Regen Biopharma Inc World Health Organization

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science